Skip to Content
Merck
CN

B8252

Bromonucleic acid

Synonym(s):

2-Bromostearic Acid

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

PubChem Substance ID:
UNSPSC Code:
41106305
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

extent of labeling

~6% Br (by weight)

storage temp.

−20°C

Application

2-Bromostearate acid (bromonucleic acid) is used to inhibit fatty acid oxidation. 2-Bromostearate acid is a mitochondrial carnitine palmitoyltransferase I (CPT I) inhibitor.

Preparation Note

Bromination of yeast RNA.

Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

C R Bliss et al.
The American journal of physiology, 263(5 Pt 1), E890-E896 (1992-11-01)
The development of glucose-stimulated insulin release and time-dependent potentiation (TDP) has been studied in isolated islets from 7-, 14-, and 21-day-old and 3-mo-old rats. Responses were small at 7 days and changed little at 14 days. At 21 days the
Effect of 2-bromostearate on glucose-phosphorylating activities and the dynamics of insulin secretion in islets of Langerhans during fasting.
Bedoya FJ, Ramirez R, Arilla E, Goberna R.
Diabetes, 33, 858-863 (1084)
S Chen et al.
Diabetes, 43(7), 878-883 (1994-07-01)
We sought to explore the emerging concept that malonyl-CoA generation, with concomitant suppression of mitochondrial carnitine palmitoyltransferase I (CPT I), represents an important component of glucose-stimulated insulin secretion (GSIS) by the pancreatic beta-cell (Prentki M, Vischer S, Glennon MC, Regazzi
J Tamarit-Rodriguez et al.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 16(3), 115-119 (1984-03-01)
The hypothesis was made of an increased oxidation of fatty acids (FFA) and a decrease of their esterification rate contributing to the islet secretory defect during starvation. 2-Bromostearate (BrS), a FFA-oxidation inhibitor, was therefore tested on the islet secretion of

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service